QNova LifeSciences Email Formats
Pharmaceutical Manufacturing • 
6751 Columbia Gateway Dr, Suite 300, United States • 1-10 Employees
QNova LifeSciences Email Formats
QNova LifeSciences uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@cssilifesciences.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@cssilifesciences.com | 60% |
{first initial}{last name} | jdoe@cssilifesciences.com | 40% |
Key Contact at QNova LifeSciences
Diane Markesich
Director Of Translational Research
Company overview
| Headquarters | 6751 Columbia Gateway Dr, Suite 300, Columbia, Maryland 21046, US |
| Phone number | +18002295764 |
| Websites | |
| NAICS | 3254 |
| Keywords | CRO, Quality Management Systems, Medical Devices, Medical Device Commercialization, Clinical Study Planning And Design, Global Regulatory Filing And Representation, Preclinical And Clinical Studies |
| Employees | 1-10 |
| Socials |
About QNova LifeSciences
QNova LifeSciences Drug & Medical Device Commercialization & Medical Device CRO Our goal is to ensure a successful and expeditious pathway to commercialization for our clients’ drugs and medical devices by providing insight-driven analysis that saves time, development costs, and resources. We enable faster, more informed decision making to increase commercial success, while reducing the risk of late-stage failures and post-authorization action. Unparalleled Success from Discovery to Commercialization • Commercialized over 500 new drugs, biologics, medical devices, and in-vitro diagnostics • Over 250 medical device 510(k) Class 1-3 submissions with 100% success. • Extensive Orphan, “First in Class,” and “First In” Indication success. • Reduced time to approval by over 600 days. • Over 100 NDA, ANDA and BLA submissions, with 96% success. • Greater than 60 EMA CHMP Marketing Authorizations. • SmartStudyTM design and feasibility assessments enhanced study efficiency and success and reduced protocol amendments by over 50%. QNova LifeSciences Medical Device CRO has experience navigating regulations in over 100 countries. Often companies struggle with the pathways for a medical device from design to commercialization because of the ambiguity and complexity of the process. Regulations and requirements change frequently and vary by notifying bodies, country, level of risk (i.e., Class 1-3), specific product claims, and intended use. Our diverse team has many years of medical device commercialization experience, with the knowledge that goes beyond published guidance, documents and initiatives. QNova LifeSciences Medical Device CRO aims to impact the timeline of regulatory clearance and increase profitability.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
QNova LifeSciences has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
QNova LifeSciences has never raised funding before.
Canada
France
Spain
Frequently asked questions
4.8
40,000 users
